Literature DB >> 8857909

Endoscopic sympathectomy treatment for craniofacial hyperhidrosis.

M C Kao1, Y L Chen, J Y Lin, C S Hsieh, J C Tsai.   

Abstract

OBJECTIVE: To present endoscopic T-2 sympathectomy as a minimally invasive therapy for craniofacial hyperhidrosis (CH).
DESIGN: Follow-up study of 30 patients with CH treated by the new method in a 4-year period. The duration of follow-up was from 8 to 44 months (mean, 15 months).
SETTING: University hospital. PATIENTS: Thirty consecutive patients with CH (18 men, 12 women) treated by the new method. All patients were essentially in good health except that they suffered from distressing CH to the extent that their daily activities were often disturbed. Their ages ranged from 7 to 63 years (mean age, 42.8 years). INTERVENTION: Endoscopic sympathectomy on both sides was carried out in a 1-stage operation for all patients. MAIN OUTCOME MEASURES: The patients were interviewed 1 week and then 3 months after surgery and then followed up by telephone interview about the alleviation or recurrence of CH and complications.
RESULTS: All of the treated patients obtained a satisfactory alleviation of CH. One case was complicated by a mild and transient ptosis of the left eye. No recurrence of CH was noticed during the follow-up period.
CONCLUSIONS: This therapeutic procedure is minimally invasive and effective. It causes minimal discomfort and was associated with no major complications in this series. The patients require only an overnight hospital stay and the operation scars are small. Endoscopic sympathectomy has proven to be an effective method in treating patients with distressing CH.

Entities:  

Mesh:

Year:  1996        PMID: 8857909     DOI: 10.1001/archsurg.1996.01430220085019

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

Review 1.  Thoracoscopic sympathectomy for palmar hyperhidrosis. Ablate or resect?

Authors:  M Hashmonai; A Assalia; D Kopelman
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

2.  Impact of T3 thoracoscopic sympathectomy on pupillary function: a cause of partial Horner's syndrome?

Authors:  Ricard Ramos; Anna Ureña; Francisco Rivas; Ivan Macia; Gabriela Rosado; Sandra Pequeño; Cristina Masuet; Maria Badia; Maribel Miguel; Miguel-Angel Delgado; Ignacio Escobar; Juan Moya
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

3.  Anatomical redistribution of sweating after T2-T3 thoracoscopic sympathicolysis: a study of 210 patients.

Authors:  R Ramos; J Moya; I Macia; R Morera; I Escobar; V Perna; F Rivas; C Masuet; J Saumench; R Villalonga
Journal:  Surg Endosc       Date:  2007-03-13       Impact factor: 4.584

Review 4.  Thoracic sympathectomy: a review of current indications.

Authors:  Moshe Hashmonai; Alan E P Cameron; Peter B Licht; Chris Hensman; Christoph H Schick
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

5.  Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.

Authors:  M Naumann; N J Lowe
Journal:  BMJ       Date:  2001-09-15

6.  Long-term results of oxybutynin use in treating facial hyperhidrosis.

Authors:  Nelson Wolosker; Marcelo Passos Teivelis; Mariana Krutman; Taiz Pereira Dozono de Almeida Campbell; Paulo Kauffman; José Ribas de Campos; Pedro Puech-Leão
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

7.  Sympathectomy for hyperhidrosis: should we place the clamps at T2-T3 or T3-T4?

Authors:  Rafael Reisfeld
Journal:  Clin Auton Res       Date:  2006-11-02       Impact factor: 4.435

Review 8.  The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review.

Authors:  Doron Kopelman; Moshe Hashmonai
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

9.  Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.

Authors:  Kai Bachmann; Nicola Standl; Jussuf Kaifi; Phillip Busch; Eva Winkler; Oliver Mann; Jakob R Izbicki; Tim Strate
Journal:  Surg Endosc       Date:  2009-03-04       Impact factor: 4.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.